Current Issue

Oct 02, 2017
Pharmaceutical Technology
Applying the right formulation strategies early in the drug development process can help avoid costly late-stage failures.
Oct 02, 2017
Pharmaceutical Technology
Lawrence Yu, deputy director of the Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), and his FDA colleague, Michael Kopcha highlight the importance of Six Sigma approaches to continuous improvement in the pharmaceutical industry.
Oct 02, 2017
Pharmaceutical Technology
Instead of rigidly applying statistical tools, experts suggest that pharma embrace statistical thinking, but focus on reducing variability and adding value for patients.
Oct 02, 2017
Pharmaceutical Technology
Just as FDA strengthens ties between reviewers and plant inspectors, proactive manufacturers are involving different disciplines in preparation for FDA audits.
Oct 02, 2017
Pharmaceutical Technology
The authors demonstrate that a proper measure of HPMC solution concentration is its electrical conductivity rather than its viscosity.
Oct 02, 2017
Pharmaceutical Technology
This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
Oct 02, 2017
Pharmaceutical Technology
This article discusses fully automatic inspection of glass and plastic containers and factors that affect particle detection rate. 
Oct 02, 2017
Pharmaceutical Technology
Is there a difference between a specification and a standard?
Oct 02, 2017
Pharmaceutical Technology
EMA and FDA guidance encourages design of drug products to improve patient compliance.
Oct 02, 2017
Pharmaceutical Technology
Manufacturers introduce innovations in glass and plastic packaging for injectables.
native1_300x100
lorem ipsum